192 related articles for article (PubMed ID: 33801272)
1. Insulin-Like Growth Factor Binding Protein-3 Exerts Its Anti-Metastatic Effect in Aerodigestive Tract Cancers by Disrupting the Protein Stability of Vimentin.
Le HT; Lee HJ; Cho J; Min HY; Lee JS; Lee SJ; Lee HY
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801272
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition.
Oh SH; Lee OH; Schroeder CP; Oh YW; Ke S; Cha HJ; Park RW; Onn A; Herbst RS; Li C; Lee HY
Mol Cancer Ther; 2006 Nov; 5(11):2685-95. PubMed ID: 17121915
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
[TBL] [Abstract][Full Text] [Related]
4. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
[TBL] [Abstract][Full Text] [Related]
6. The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ).
Shen X; Xi G; Wai C; Clemmons DR
J Biol Chem; 2015 May; 290(18):11578-90. PubMed ID: 25787077
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
[TBL] [Abstract][Full Text] [Related]
9. Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity.
Liu H; Li L; Chen H; Kong R; Pan S; Hu J; Wang Y; Li Y; Sun B
Oncotarget; 2017 Sep; 8(37):61674-61686. PubMed ID: 28977895
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes Its ligand-dependent action on cell migration.
Xu Q; Yan B; Li S; Duan C
J Biol Chem; 2004 Feb; 279(6):4269-77. PubMed ID: 14645245
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin β4 expression.
Lee HJ; Lee JS; Hwang SJ; Lee HY
Oncotarget; 2015 Jun; 6(17):15150-63. PubMed ID: 25945837
[TBL] [Abstract][Full Text] [Related]
12. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms.
Mazerbourg S; Zapf J; Bar RS; Brigstock DR; Lalou C; Binoux M; Monget P
Endocrinology; 1999 Sep; 140(9):4175-84. PubMed ID: 10465290
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis.
Liu B; Lee KW; Anzo M; Zhang B; Zi X; Tao Y; Shiry L; Pollak M; Lin S; Cohen P
Oncogene; 2007 Mar; 26(12):1811-9. PubMed ID: 16983336
[TBL] [Abstract][Full Text] [Related]
15. Methylation status of insulin-like growth factor-binding protein 7 concurs with the malignance of oral tongue cancer.
Chen LH; Liu DW; Chang JL; Chen PR; Hsu LP; Lin HY; Chou YF; Lee CF; Yang MC; Wen YH; Hsu WL; Weng CF
J Exp Clin Cancer Res; 2015 Feb; 34(1):20. PubMed ID: 25880247
[TBL] [Abstract][Full Text] [Related]
16. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
[TBL] [Abstract][Full Text] [Related]
17. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
Han VK; Bassett N; Walton J; Challis JR
J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
[TBL] [Abstract][Full Text] [Related]
18. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
Hsieh T; Gordon RE; Clemmons DR; Busby WH; Duan C
J Biol Chem; 2003 Oct; 278(44):42886-92. PubMed ID: 12917428
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
20. IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.
Takaoka M; Kim SH; Okawa T; Michaylira CZ; Stairs DB; Johnstone CN; Andl CD; Rhoades B; Lee JJ; Klein-Szanto AJ; El-Deiry WS; Nakagawa H
Cancer Biol Ther; 2007 Apr; 6(4):534-40. PubMed ID: 17457048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]